The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study (Q43824306)
Jump to navigation
Jump to search
scientific article published in September 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study |
scientific article published in September 2001 |
Statements
1 reference
The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study (English)
1 reference
Diamond TH
1 reference
Winters J
1 reference
Smith A
1 reference
De Souza P
1 reference
Kersley JH
1 reference
Lynch WJ
1 reference
Bryant C
1 reference
1 September 2001
1 reference
Identifiers
1 reference